Narcotic antagonists in the therapy of shock

Details Narcotic antagonists in the therapy of shock Narcotic antagonists in the therapy of shock

1979-01-16

1981-05-12

Ore, Dale R.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

424 95, A01N 4342

Patent

active

042671825

ABSTRACT:
The use of narcotic antagonists (e.g., naloxone) in shock therapy is disced.

REFERENCES:
patent: 2364833 (1944-12-01), Weijlard et al.
patent: 2891954 (1959-06-01), Weijlard
patent: 3148118 (1964-09-01), Thesing et al.
patent: 3214341 (1965-10-01), Feinstone
patent: 3254088 (1966-05-01), Lewenstein et al.
patent: 3717643 (1973-02-01), Archer
patent: 3823234 (1974-07-01), Mauvernay
patent: 4001247 (1977-01-01), Zimmerman et al.
patent: 4035511 (1977-07-01), Messing et al.
patent: 4042682 (1977-08-01), Spector
M. Woods et al., The Physiologist, 8/31/78, vol. 21, p. 129.
Chem. Abs., 1978, vol. 88, pp. 69112x, 32035y.
Chem. Abs., 1976, vol. 85, p. 171810y.
Chem. Abs., 1977, vol. 86, pp. 12304r.
Merck Manual, 11th Edition, 1/1967, pp. 154-159, 1538-1540 & 1547.

Affiliated with

Also associated with

Rating

Narcotic antagonists in the therapy of shock does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Narcotic antagonists in the therapy of shock, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Narcotic antagonists in the therapy of shock will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2046572